KCNK3 and pulmonary arterial hypertension: Consequently, it is very likely that SrcTK as the essential regulator for K+ channel including KCNK3/TASK-1 activity plays a pivotal role for the development of potent inhibitor of SrcTK dasatinib-induced PAH [184,238,239].